← Leaderboards
Russell E Nicholls
Columbia University Health Sciences
$2,030,292
Attributed
$4,060,583
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $876.9K · FY2015–21$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,060,583 · 2
By mechanism
R01$4,060,583 · 2
Top collaborators
- Ottavio Arancio5 shared
- M. Maral Mouradian5 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- David Sulzer$25,519,828
- Mark W Albers$13,654,727
- Richard Mayeux$113,943,785
- Andrea Baccarelli$24,279,074
- Serge E Przedborski$23,881,284
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposMethyltransferaseInsightNerve DegenerationSubstrate SpecificityProtein Serine/Threonine PhosphataseTransgenic MiceEnzymesMethylationMutant Strains MicePhosphorylationBehavioralPreventionProteinsPathway InteractionsBrainCatalytic DomainAnimal ModelAffectIn VivoMolecularPathologicBrain DiseasesAnimals
Grant awards (10)
PP2A Dysregulation in the Pathogenesis of alpha-Synucleinopathies$411,687
R01 · FY2021 · NS
PP2A Dysregulation in the Pathogenesis of alpha-Synucleinopathies$451,511
R01 · FY2020 · NS
PP2A Dysregulation in the Pathogenesis of alpha-Synucleinopathies$415,807
R01 · FY2019 · NS
The regulation of beta-amyloid sensitivity and Alzheimer's related impairments by PP2A$350,000
R01 · FY2019 · NS
PP2A Dysregulation in the Pathogenesis of alpha-Synucleinopathies$504,636
R01 · FY2018 · NS
The regulation of beta-amyloid sensitivity and Alzheimer's related impairments by PP2A$350,000
R01 · FY2018 · NS
PP2A Dysregulation in the Pathogenesis of alpha-Synucleinopathies$526,942
R01 · FY2017 · NS
The regulation of beta-amyloid sensitivity and Alzheimer's related impairments by PP2A$350,000
R01 · FY2017 · NS
The regulation of beta-amyloid sensitivity and Alzheimer's related impairments by PP2A$350,000
R01 · FY2016 · NS
The regulation of beta-amyloid sensitivity and Alzheimer's related impairments by PP2A$350,000
R01 · FY2015 · NS